Breast Cancer Vaccine
Aromatase inhibitors increase tumor sensitivity to cytotoxicity
Published in Women's Health Weekly, December 1st, 2005
"A randomized, placebo-controlled phase III trial of the breast cancer vaccine Theratope (Biomira Corporation, Edmonton, Canada), which expresses the under-glycosylated, mucin-associated peptide STn showed that patients treated concomitantly with hormone therapy plus vaccine survived significantly longer than patients treated with hormone therapy plus a control vaccine. The objective of this study was to elucidate a mechanism to explain this effect," investigators in the United States report.
"Tumor cells characterized...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cervical Cancer
HPV DNA testing shows promise to improve cervical cancer screening and testing - Endometrial Cancer
Physicians urged to assess adnexa in premenopausal women with endometrial cancer - HIV/AIDS Transmission
Increased breast milk HIV-1 suppression seen with nevirapine - Osteoporosis
Postmenopausal osteoporosis risk associated with haplotype in premenopausal women - Sexual & Reproductive Health
Hepatitis C virus RNA is present in the genital tracts of HCV/HIV-1-coinfected women - Adenosine Deaminase
Prognostic ability of adenosine deaminase activity studied - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
